Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiake Xu

Showing results (171-180 of 401) with videos related to

Pageof 41
Sort By:
Journal of Cellular Physiology|March 1, 2019
Tiliroside is a new potential therapeutic drug for osteoporosis in miceKai Li, Yu Xiao, Ziyi Wang, et al.
Cell Proliferation|August 8, 2023
IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysisXiaoxiao Xie, Weiwei Chen, Minglian Xu, et al.
International Immunopharmacology|March 6, 2022
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signalingFeng Long, Runfeng Chen, Yuangang Su, et al.
Journal of Translational Medicine|November 23, 2023
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosisTao Yang, Weiwei Chen, Kai Gan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2023
Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca<sup>2+</sup> signaling pathways mediated by ROSRan Sun, Na Hai, Biao Yang, et al.
Journal of Cellular and Molecular Medicine|September 17, 2020
Maackiain dampens osteoclastogenesis via attenuating RANKL-stimulated NF-κB signalling pathway and NFATc1 activityYuhao Liu, Weizai Zeng, Chao Ma, et al.
Archives of Biochemistry and Biophysics|April 22, 2018
Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3Dezhi Song, Zhen Cao, Jennifer Tickner, et al.
The Journal of Biological Chemistry|May 3, 2011
EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinaseShek Man Chim, An Qin, Jennifer Tickner, et al.
Tissue Engineering. Part A|April 19, 2011
Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit modelJimin Chen, Qian Yu, Bing Wu, et al.
Journal of Cellular Physiology|August 28, 2018
Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathwaysLilei He, Guoju Hong, Lin Zhou, et al.
Pageof 41

Showing results (171-180 of 401) with videos related to

Sort By:
Pageof 41
Journal of Cellular Physiology|March 1, 2019
Tiliroside is a new potential therapeutic drug for osteoporosis in miceKai Li, Yu Xiao, Ziyi Wang, et al.
Cell Proliferation|August 8, 2023
IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysisXiaoxiao Xie, Weiwei Chen, Minglian Xu, et al.
International Immunopharmacology|March 6, 2022
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signalingFeng Long, Runfeng Chen, Yuangang Su, et al.
Journal of Translational Medicine|November 23, 2023
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosisTao Yang, Weiwei Chen, Kai Gan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2023
Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca<sup>2+</sup> signaling pathways mediated by ROSRan Sun, Na Hai, Biao Yang, et al.
Journal of Cellular and Molecular Medicine|September 17, 2020
Maackiain dampens osteoclastogenesis via attenuating RANKL-stimulated NF-κB signalling pathway and NFATc1 activityYuhao Liu, Weizai Zeng, Chao Ma, et al.
Archives of Biochemistry and Biophysics|April 22, 2018
Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3Dezhi Song, Zhen Cao, Jennifer Tickner, et al.
The Journal of Biological Chemistry|May 3, 2011
EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinaseShek Man Chim, An Qin, Jennifer Tickner, et al.
Tissue Engineering. Part A|April 19, 2011
Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit modelJimin Chen, Qian Yu, Bing Wu, et al.
Journal of Cellular Physiology|August 28, 2018
Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathwaysLilei He, Guoju Hong, Lin Zhou, et al.
Pageof 41